AbbVie Short-Term Borrowings decreased by 34.1% to $2.50B in Q4 2025 compared to the prior quarter. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows an upward trend with a 136.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.00M | $16.00M | $14.00M | $12.00M | $17.00M | $10.00M | $1.00M | $1.00M | $0.00 | $2.00M | $0.00 | $3.00M | $0.00 | $1.59B | $5.56B | $3.79B | $2.50B |
| QoQ Change | — | -5.9% | -12.5% | -14.3% | +41.7% | -41.2% | -90.0% | +0.0% | -100.0% | — | -100.0% | — | -100.0% | — | +248.8% | -31.8% | -34.1% |
| YoY Change | — | — | — | — | +0.0% | -37.5% | -92.9% | -91.7% | -100.0% | -80.0% | -100.0% | +200.0% | — | >999% | — | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.